The efficacy of guaifenesin in the treatment of adult polyglucosan body disease

Awardee: Akman Hasan

Institution: Columbia University Medical Center

Award Amount: $50,500

Funding Period: January 1, 2017 - December 31, 2017

Previous
Previous

Rational Design of Effective Therapeutics for Treatment of the 1282X CFTR Disorder

Next
Next

Treatment of adult polyglucosan body disease caused by an intronic mutation in glycogen branching enzyme gene.